Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/94259
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCugati, S.-
dc.contributor.authorGilhotra, J.S.-
dc.contributor.authorLake, S.-
dc.contributor.authorGordon, D.L.-
dc.date.issued2014-
dc.identifier.citationClinical and Experimental Ophthalmology, 2014; 42(5):494-495-
dc.identifier.issn1442-6404-
dc.identifier.issn1442-9071-
dc.identifier.urihttp://hdl.handle.net/2440/94259-
dc.description.statementofresponsibilitySudha Cugati, Jagjit Singh Gilhotra, Stewart Lake, and David L Gordon-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2013 Royal Australian and New Zealand College of Ophthalmologists-
dc.source.urihttp://dx.doi.org/10.1111/ceo.12252-
dc.subjectHumans-
dc.subjectTuberculosis, Ocular-
dc.subjectCarcinoma, Transitional Cell-
dc.subjectUveitis-
dc.subjectBCG Vaccine-
dc.subjectAdjuvants, Immunologic-
dc.subjectGlucocorticoids-
dc.subjectAntitubercular Agents-
dc.subjectFluorescein Angiography-
dc.subjectImmunotherapy-
dc.subjectCombined Modality Therapy-
dc.subjectAdministration, Intravesical-
dc.subjectAged-
dc.subjectFemale-
dc.subjectMale-
dc.subjectUrinary Bladder Neoplasms-
dc.subjectImmune Reconstitution Inflammatory Syndrome-
dc.titleOcular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma-
dc.typeJournal article-
dc.identifier.doi10.1111/ceo.12252-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 2
Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.